DBV Technologies (DBVT) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.02% |
| Dec 31, 2025 | -178.08% |
| Sep 30, 2025 | 32.33% |
| Jun 30, 2025 | -696.17% |
| Mar 31, 2025 | 60.06% |
| Dec 31, 2024 | 30.05% |
| Sep 30, 2024 | 29.92% |
| Jun 30, 2024 | 34.78% |
| Mar 31, 2024 | 28.18% |
| Dec 31, 2023 | 5.21% |
| Sep 30, 2023 | 14.27% |
| Jun 30, 2023 | 9.53% |
| Mar 31, 2023 | 8.08% |
| Dec 31, 2022 | 1.63% |
| Sep 30, 2022 | 14.24% |
| Jun 30, 2022 | -234.64% |
| Mar 31, 2022 | 4.14% |
| Dec 31, 2021 | 21.28% |
| Sep 30, 2021 | 21.75% |
| Jun 30, 2021 | 17.68% |
| Mar 31, 2021 | 22.35% |
| Dec 31, 2020 | 11.32% |
| Sep 30, 2020 | 11.00% |
| Jun 30, 2020 | 13.45% |
| Mar 31, 2020 | -50.96% |
| Dec 31, 2019 | -39.39% |
| Sep 30, 2019 | -13.34% |
| Dec 31, 2018 | 12.62% |
| Sep 30, 2018 | 2.54% |